ATAI

ATAI Life Sciences N.V.

1.89 USD
+0.01 (+0.53%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ATAI Life Sciences N.V. stock is up 3.28% since 30 days ago. The next earnings date is Mar 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Jan 17:43 16 Aug, 2024 7.50 PUT 50 5

About ATAI Life Sciences N.V.

Atai Life Sciences N.V. operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD)